Title |
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
|
---|---|
Published in |
Drugs, February 2019
|
DOI | 10.1007/s40265-019-1054-3 |
Pubmed ID | |
Authors |
Khalid Eljaaly, Aisha Alharbi, Samah Alshehri, Jessica K. Ortwine, Jason M. Pogue |
X Demographics
The data shown below were collected from the profiles of 68 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Saudi Arabia | 20 | 29% |
United States | 8 | 12% |
United Kingdom | 2 | 3% |
Malaysia | 2 | 3% |
South Africa | 1 | 1% |
United Arab Emirates | 1 | 1% |
Russia | 1 | 1% |
Kuwait | 1 | 1% |
Spain | 1 | 1% |
Other | 3 | 4% |
Unknown | 28 | 41% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 55 | 81% |
Scientists | 8 | 12% |
Practitioners (doctors, other healthcare professionals) | 4 | 6% |
Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 169 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 26 | 15% |
Researcher | 15 | 9% |
Student > Master | 15 | 9% |
Other | 13 | 8% |
Student > Ph. D. Student | 12 | 7% |
Other | 29 | 17% |
Unknown | 59 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 12% |
Biochemistry, Genetics and Molecular Biology | 19 | 11% |
Chemistry | 13 | 8% |
Immunology and Microbiology | 11 | 7% |
Other | 20 | 12% |
Unknown | 62 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#753,470
of 25,718,113 outputs
Outputs from Drugs
#60
of 3,482 outputs
Outputs of similar age
#17,692
of 448,759 outputs
Outputs of similar age from Drugs
#4
of 50 outputs
Altmetric has tracked 25,718,113 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,482 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,759 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.